Order Article Reprints

Oesch-Régeni B, Germann N, Hafer G, Schmid D, Arn N. The Effect on Quality of Life of Therapeutic Plasmapheresis and Intravenous Immunoglobulins on a Population of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients with Elevated β-Adrenergic and M3-Muscarinic Receptor Antibodies—A Pilot Study. Journal of Clinical Medicine. 2025; 14(11):3802. https://doi.org/10.3390/jcm14113802

Oesch-Régeni, Boglárka, Nicolas Germann, Georg Hafer, Dagmar Schmid, and Norbert Arn. 2025. "The Effect on Quality of Life of Therapeutic Plasmapheresis and Intravenous Immunoglobulins on a Population of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients with Elevated β-Adrenergic and M3-Muscarinic Receptor Antibodies—A Pilot Study" Journal of Clinical Medicine 14, no. 11: 3802. https://doi.org/10.3390/jcm14113802

Oesch-Régeni, B., Germann, N., Hafer, G., Schmid, D., & Arn, N. (2025). The Effect on Quality of Life of Therapeutic Plasmapheresis and Intravenous Immunoglobulins on a Population of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients with Elevated β-Adrenergic and M3-Muscarinic Receptor Antibodies—A Pilot Study. Journal of Clinical Medicine, 14(11), 3802. https://doi.org/10.3390/jcm14113802